169 related articles for article (PubMed ID: 16022944)
1. Ecstasy and cocaine: patterns of use among prime age individuals in Amsterdam.
van Ours JC
Addict Behav; 2005 Aug; 30(7):1468-73. PubMed ID: 16022944
[TBL] [Abstract][Full Text] [Related]
2. Correlates of Ecstasy use in middle age and beyond.
Williams P
Drug Alcohol Rev; 2005 Jan; 24(1):33-8. PubMed ID: 16191719
[TBL] [Abstract][Full Text] [Related]
3. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
Thomasius R; Gouzoulis-Mayfrank E; Karus C; Wiedenmann H; Hermle L; Sack PM; Zeichner D; Küstner U; Schindler A; Krüger A; Uhlmann S; Petersen KU; Zapletalova P; Wartberg L; Schütz CG; Schulte-Markwort M; Obrocki J; Heinz A; Schmoldt A;
Fortschr Neurol Psychiatr; 2004 Dec; 72(12):679-95. PubMed ID: 15580533
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of ecstasy use and harms in Australia.
Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
[TBL] [Abstract][Full Text] [Related]
5. [Clinical aspects of abuse drugs mainly used by adolescents].
Franceschini E; Baronti R
Minerva Pediatr; 2001 Oct; 53(5):455-63. PubMed ID: 11668269
[No Abstract] [Full Text] [Related]
6. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
[No Abstract] [Full Text] [Related]
7. Is cannabis a stepping-stone for cocaine?
van Ours JC
J Health Econ; 2003 Jul; 22(4):539-54. PubMed ID: 12842314
[TBL] [Abstract][Full Text] [Related]
8. Club drug use in Germany.
Soellner R
Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
[TBL] [Abstract][Full Text] [Related]
9. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.
Schifano F; Oyefeso A; Corkery J; Cobain K; Jambert-Gray R; Martinotti G; Ghodse AH
Hum Psychopharmacol; 2003 Oct; 18(7):519-24. PubMed ID: 14533133
[TBL] [Abstract][Full Text] [Related]
10. [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
Hedetoft C; Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6907-11. PubMed ID: 10643376
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes.
Marsden J; Stillwell G; Barlow H; Boys A; Taylor C; Hunt N; Farrell M
Addiction; 2006 Jul; 101(7):1014-26. PubMed ID: 16771893
[TBL] [Abstract][Full Text] [Related]
13. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
Cance JD; Ashley OS; Penne MA
J Adolesc Health; 2005 Nov; 37(5):409. PubMed ID: 16227128
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
de Win MM; Schilt T; Reneman L; Vervaeke H; Jager G; Dijkink S; Booij J; van den Brink W
J Psychopharmacol; 2006 Mar; 20(2):226-35. PubMed ID: 16510480
[TBL] [Abstract][Full Text] [Related]
15. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
[TBL] [Abstract][Full Text] [Related]
16. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
Yen CF; Hsu SY; Cheng CP
Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
[TBL] [Abstract][Full Text] [Related]
17. Consumption and dangers of ecstasy: an amphetamine derivative with a misleading reputation of safety.
Prescrire Int; 1999 Dec; 8(44):188-9. PubMed ID: 11503823
[TBL] [Abstract][Full Text] [Related]
18. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
19. [Visits to the emergency department due to ecstasy (MDMA) and amphetamine derivative consumption: Epidemiological, clinical and evolutional profile].
Galicia M; Nogué S; Sanjurjo E; Miró O
Rev Clin Esp; 2010 Sep; 210(8):371-8. PubMed ID: 20673888
[TBL] [Abstract][Full Text] [Related]
20. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
Brunt TM; Niesink RJ; van den Brink W
Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
